对加特迈尔·D、马鲁胡姆·博纳尔·M、苏西洛·A、哈里穆尔蒂·K所著《中度和重度新冠肺炎患者中白细胞介素-6、白细胞介素-10、肿瘤坏死因子-α与急性肾损伤的关系[摘要POS-014]》的勘误。2022年；7（增刊1）：S6。
Corrigendum to Gathmyr D, Maruhum Bonar M, Susilo A, Harimurti K. "The relationship between IL-6, IL-10, TNF-α with AKI in moderate and severe COVID-19 patients [abstract POS-014]." . 2022;7(suppl 1):S6.
出版信息
Kidney Int Rep. 2022 Apr;7(4):935. doi: 10.1016/j.ekir.2022.03.003. Epub 2022 Mar 9.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2022.01.022.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2022.01.022。]
相似文献
1
Corrigendum to Gathmyr D, Maruhum Bonar M, Susilo A, Harimurti K. "The relationship between IL-6, IL-10, TNF-α with AKI in moderate and severe COVID-19 patients [abstract POS-014]." . 2022;7(suppl 1):S6.对加特迈尔·D、马鲁胡姆·博纳尔·M、苏西洛·A、哈里穆尔蒂·K所著《中度和重度新冠肺炎患者中白细胞介素-6、白细胞介素-10、肿瘤坏死因子-α与急性肾损伤的关系[摘要POS-014]》的勘误。2022年；7（增刊1）：S6。
Kidney Int Rep. 2022 Apr;7(4):935. doi: 10.1016/j.ekir.2022.03.003. Epub 2022 Mar 9.
2
Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [ 2021; https://doi.org/10.1016/j.ekir.2021.08.020].《依那卡塞在曾接受西那卡塞治疗的继发性甲状旁腺功能亢进患者中的疗效》勘误，[2021年；https://doi.org/10.1016/j.ekir.2021.08.020] 。
Kidney Int Rep. 2021 Nov 5;6(11):2936-2937. doi: 10.1016/j.ekir.2021.09.011. eCollection 2021 Nov.
3
Corrigendum to "The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients" [Kidney Int. Rep. 2020 1416-1421].《中国血液透析患者中 SARS-CoV-2 感染的累积率》[《肾脏国际报告》2020 年第 1416 - 1421 页]勘误
Kidney Int Rep. 2021 Sep;6(9):2525. doi: 10.1016/j.ekir.2021.07.021. Epub 2021 Sep 2.
4
Corrigendum to Inaba M, Une Y, Ikejiri K, et al. "Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial." . 2022;7:177-188.稻叶真人、宇根洋、池尻健等所著《日本接受血液透析的高磷血症患者中替那帕诺的剂量反应——一项2期随机试验》的勘误。2022年；7：177 - 188。
Kidney Int Rep. 2022 Jul 5;7(7):1729. doi: 10.1016/j.ekir.2022.06.008. eCollection 2022 Jul.
5
Corrigendum to "Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population." . 2020;5:694-705.《木村T、斯奈德R、野崎K。日本人群中慢性肾脏病和贫血的诊断模式》勘误。2020年；5:694 - 705。
Kidney Int Rep. 2020 Sep 3;5(9):1614. doi: 10.1016/j.ekir.2020.08.006. eCollection 2020 Sep.
6
Corrigendum to "Transjugular Kidney Biopsy as a Safe Method to Increase the Etiological Diagnosis in Kidney Disease" 2021;6:2535-2536.《经颈静脉肾活检：一种增加肾脏疾病病因诊断的安全方法》勘误 2021 年；6：2535 - 2536。
Kidney Int Rep. 2021 Oct 20;6(12):3095. doi: 10.1016/j.ekir.2021.10.013. eCollection 2021 Dec.
7
Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy. 2021;6:91-100.对Shi M、Yu S、Ouyang Y等人的勘误：家族性IgA肾病患者终末期肾病终生风险增加。2021年；6：91 - 100。
Kidney Int Rep. 2021 Mar 11;6(5):1484. doi: 10.1016/j.ekir.2021.03.871. eCollection 2021 May.
8
Corrigendum to "Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD." . 2020;5:1383-1384.《多囊肾病中通过单次测量肾脏体积估算生长速率》勘误。2020年；5：1383 - 1384。
Kidney Int Rep. 2021 Feb 10;6(2):552. doi: 10.1016/j.ekir.2020.11.012. eCollection 2021 Feb.
9
Corrigendum to "Vimala, A. Hyponatremia among patients admitted in critical care unit at tertiary care hospitals." . 2020;5:S230.《维玛拉，A. 三级护理医院重症监护病房患者低钠血症》勘误。2020年；5：S230。
Kidney Int Rep. 2020 May 11;5(6):959. doi: 10.1016/j.ekir.2020.05.002. eCollection 2020 Jun.
10
Corrigendum to "Boudard D, Aureli F, Laurent B, et al. Chronic oral exposure to synthetic amorphous silica (NM-200) results in renal and liver lesions in mice." . 2019;4:1463-1471.《“布达尔D、奥雷利F、洛朗B等人。慢性经口暴露于合成无定形二氧化硅（NM - 200）导致小鼠肾脏和肝脏损伤”》勘误。2019年；4:1463 - 1471。
Kidney Int Rep. 2020 Mar 3;5(3):382. doi: 10.1016/j.ekir.2020.01.002. eCollection 2020 Mar.
Zotero 插件